| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.108.777102 |
| P698 | PubMed publication ID | 18794392 |
| P50 | author | Stefanie Dimmeler | Q110856 |
| Andreas Zeiher | Q501318 | ||
| Birgit Assmus | Q86379036 | ||
| Alexandra Aicher | Q86950497 | ||
| Winfried Brenner | Q89882342 | ||
| Stephan Fichtlscherer | Q114309453 | ||
| Florian Seeger | Q114320863 | ||
| Volker Schächinger | Q117254768 | ||
| Natascha Döbert | Q117267668 | ||
| P2093 | author name string | Christian Menzel | |
| Jürgen Diener | |||
| Rainer Röver | |||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1425-1432 | |
| P577 | publication date | 2008-09-15 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium | |
| P478 | volume | 118 |
| Q36933345 | A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice |
| Q50701050 | Advances in cardiovascular molecular imaging for tracking stem cell therapy |
| Q37439217 | Aging decreases expression and activity of glutathione peroxidase-1 in human endothelial progenitor cells |
| Q48965797 | An in vitro investigation to assess procedure parameters for injecting therapeutic hydrogels into the myocardium |
| Q33680007 | Assessment and optimization of cell engraftment after transplantation into the heart |
| Q50279365 | Augmented neovascularization with magnetized endothelial progenitor cells in rats with hind-limb ischemia |
| Q36127860 | Biomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction |
| Q37194005 | Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction. |
| Q41813361 | C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways |
| Q38161754 | Can stem cells really regenerate the human heart? Use your noggin, dickkopf! Lessons from developmental biology |
| Q37371934 | Cardiac cell repair therapy: a clinical perspective |
| Q37769840 | Cardiac cell therapy: lessons from clinical trials |
| Q33749374 | Cardiac stem cell therapy for cardiac repair |
| Q30470859 | Cardiovascular molecular imaging: focus on clinical translation |
| Q26765916 | Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration |
| Q37776514 | Cell therapy for heart failure: the need for a new therapeutic strategy |
| Q37696967 | Cell therapy for the treatment of coronary heart disease: a critical appraisal |
| Q35589728 | Cell tracking in cardiac repair: what to image and how to image. |
| Q33713519 | Cell-based therapy for heart disease: a clinically oriented perspective |
| Q37178001 | Cells for the treatment, prevention, and cure of cardiovascular disease. |
| Q42875580 | Cellular encapsulation enhances cardiac repair |
| Q39410733 | Cellular mechanisms underlying cardiac engraftment of stem cells. |
| Q26851906 | Clinical imaging in regenerative medicine |
| Q39410807 | Combined delivery of bone marrow-derived mononuclear cells in chronic ischemic heart disease: rationale and study design. |
| Q36578130 | Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction |
| Q47161681 | Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells. |
| Q61651435 | Delivery of Biologics in Cardiovascular Regenerative Medicine |
| Q34260802 | Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging |
| Q34074673 | Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial |
| Q53186699 | Effects of myocardial postconditioning on the recruitment of endothelial progenitor cells |
| Q35944159 | Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective |
| Q34055868 | Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix |
| Q38401259 | Fluorine-19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications |
| Q36114568 | Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy |
| Q41120104 | Homing of stem cells to ischemic myocardium |
| Q26774939 | How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart? |
| Q37871466 | Imaging cardiac stem cell therapy: translations to human clinical studies |
| Q38168207 | Imaging cardiac stem cell transplantation using radionuclide labeling techniques: clinical applications and future directions. |
| Q26765900 | In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine |
| Q36260404 | Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium |
| Q34065508 | Ischemia induces P-selectin-mediated selective progenitor cell engraftment in the isolated-perfused heart |
| Q34090699 | LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction |
| Q34288961 | Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes |
| Q41482927 | Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells. |
| Q35068527 | Magnetic Enhancement of Cell Retention, Engraftment, and Functional Benefit after Intracoronary Delivery of Cardiac-Derived Stem Cells in a Rat Model of Ischemia/Reperfusion |
| Q34159905 | Marrow Stromal Cells Differentiate Into Vasculature After Allogeneic Transplantation Into Ischemic Myocardium |
| Q38003151 | Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity |
| Q38096580 | Molecular imaging: the key to advancing cardiac stem cell therapy |
| Q39129395 | Multimodality molecular imaging in cardiac regenerative therapy |
| Q52766189 | Myocardial Injury as a New Target for Cell Therapy in Patients With Chronic Heart Failure: When Something Bad Is Actually Good? |
| Q55077069 | Myocardial Ischemia and Mobilization of Circulating Progenitor Cells. |
| Q38129057 | Non-invasive In-Vivo Imaging of Stem Cells after Transplantation in Cardiovascular Tissue |
| Q37767614 | Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. |
| Q37907966 | Noninvasive stem cell tracking |
| Q33951300 | Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct |
| Q36307762 | Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease |
| Q34756310 | Optimized delivery system achieves enhanced endomyocardial stem cell retention |
| Q38982831 | Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology |
| Q41785188 | PET Cell Tracking Using 18F-FLT is Not Limited by Local Reuptake of Free Radiotracer. |
| Q35587462 | Perfusion defect size predicts engraftment but not early retention of intra-myocardially injected cardiosphere-derived cells after acute myocardial infarction |
| Q89472124 | Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting |
| Q37606452 | Pulp cell tracking by radionuclide imaging for dental tissue engineering. |
| Q49288386 | Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease. |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q37444118 | Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction |
| Q33490304 | Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease |
| Q38016714 | SDF-1 in myocardial repair |
| Q34410872 | Safe genetic modification of cardiac stem cells using a site-specific integration technique |
| Q43239856 | Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells |
| Q40596219 | Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis |
| Q30541317 | Small Molecule Agonist of Very Late Antigen-4 (VLA-4) Integrin Induces Progenitor Cell Adhesion |
| Q39762671 | Stem Cell Tracking in Human Trials: A Meta-Regression |
| Q38903653 | Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration |
| Q42137997 | Stem Cells as a Tool for Breast Imaging |
| Q85240790 | Stem and progenitor cell-based therapy approaches: current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy |
| Q34981433 | Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges |
| Q26861615 | Stem cell imaging: from bench to bedside |
| Q36836349 | Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology |
| Q33352048 | Stem cells for cardiac repair in acute myocardial infarction |
| Q34795299 | Strategies for cardiac regeneration and repair |
| Q89604473 | The clinical potential of gene editing as a tool to engineer cell-based therapeutics |
| Q37766123 | The paracrine effect: pivotal mechanism in cell-based cardiac repair |
| Q34140406 | Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function. |
| Q38180960 | Tracking gene and cell fate for therapeutic gain |
| Q37794511 | Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging |
| Q37957060 | Using Biomaterials to Improve the Efficacy of Cell Therapy Following Acute Myocardial Infarction |
| Q42578005 | Von willebrand factor increases endothelial cell adhesiveness for human mesenchymal stem cells by activating p38 mitogen-activated protein kinase |
| Q33578162 | c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart |
Search more.